Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Current Opinion in Pharmacology
|
November 21, 2017
Ensuring quality pharmacokinetic analyses in antimicrobial drug development programs
Elizabeth A Lakota, Justin C Bader, Christopher M Rubino
Clinical Pharmacokinetics
|
April 30, 2021
Pharmacokinetics of Selinexor: The First-in-Class Selective Inhibitor of Nuclear Export
Justin C Bader, Albiruni R Abdul Razak, Sharon Shacham, et al.
The Journal of Antimicrobial Chemotherapy
|
January 6, 2018
We can do better: a fresh look at echinocandin dosing
Justin C Bader, Sujata M Bhavnani, David R Andes, et al.
The Journal of Antimicrobial Chemotherapy
|
January 18, 2018
We can do better: a fresh look at echinocandin dosing
Justin C Bader, Sujata M Bhavnani, David R Andes, et al.
Cancer Chemotherapy and Pharmacology
|
March 26, 2021
Selinexor population pharmacokinetic and exposure-response analyses to support dose optimization in patients with diffuse large B-cell lymphoma
Hongmei Xu, Hanbin Li, Russ Wada, et al.
Open Forum Infectious Diseases
|
December 25, 2018
Time for Precision: A World Without Susceptibility Breakpoints
Justin C Bader, Elizabeth A Lakota, David R Andes, et al.
Antimicrobial Agents and Chemotherapy
|
January 31, 2018
Norepinephrine in Combination with Antibiotic Therapy Increases both the Bacterial Replication Rate and Bactericidal Activity
Paul G Ambrose, Brian D VanScoy, John Adams, et al.
Antimicrobial Agents and Chemotherapy
|
January 31, 2018
<i>In Vivo</i> Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model
Miao Zhao, Alexander J Lepak, Brian VanScoy, et al.
Antimicrobial Agents and Chemotherapy
|
December 19, 2018
Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniae
Alexander J Lepak, Miao Zhao, Qingmei Liu, et al.
Antimicrobial Agents and Chemotherapy
|
March 21, 2018
Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata
Justin C Bader, Elizabeth A Lakota, Shawn Flanagan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Current Opinion in Pharmacology
|
November 21, 2017
Ensuring quality pharmacokinetic analyses in antimicrobial drug development programs
Elizabeth A Lakota, Justin C Bader, Christopher M Rubino
Clinical Pharmacokinetics
|
April 30, 2021
Pharmacokinetics of Selinexor: The First-in-Class Selective Inhibitor of Nuclear Export
Justin C Bader, Albiruni R Abdul Razak, Sharon Shacham, et al.
The Journal of Antimicrobial Chemotherapy
|
January 6, 2018
We can do better: a fresh look at echinocandin dosing
Justin C Bader, Sujata M Bhavnani, David R Andes, et al.
The Journal of Antimicrobial Chemotherapy
|
January 18, 2018
We can do better: a fresh look at echinocandin dosing
Justin C Bader, Sujata M Bhavnani, David R Andes, et al.
Cancer Chemotherapy and Pharmacology
|
March 26, 2021
Selinexor population pharmacokinetic and exposure-response analyses to support dose optimization in patients with diffuse large B-cell lymphoma
Hongmei Xu, Hanbin Li, Russ Wada, et al.
Open Forum Infectious Diseases
|
December 25, 2018
Time for Precision: A World Without Susceptibility Breakpoints
Justin C Bader, Elizabeth A Lakota, David R Andes, et al.
Antimicrobial Agents and Chemotherapy
|
January 31, 2018
Norepinephrine in Combination with Antibiotic Therapy Increases both the Bacterial Replication Rate and Bactericidal Activity
Paul G Ambrose, Brian D VanScoy, John Adams, et al.
Antimicrobial Agents and Chemotherapy
|
January 31, 2018
<i>In Vivo</i> Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model
Miao Zhao, Alexander J Lepak, Brian VanScoy, et al.
Antimicrobial Agents and Chemotherapy
|
December 19, 2018
Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniae
Alexander J Lepak, Miao Zhao, Qingmei Liu, et al.
Antimicrobial Agents and Chemotherapy
|
March 21, 2018
Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata
Justin C Bader, Elizabeth A Lakota, Shawn Flanagan, et al.
Page
of 2